New spatial biology platform launches at UCLA accelerator

Meteor Biotech, a leading developer of spatial omics technology and region-targeted cell sorting devices, has announced the installation of its next-generation spatial biology platform, CosmoSort, at Magnify, the California NanoSystems Institute (CNSI) incubator at UCLA. The site also marks the opening of Meteor Biotech’s newly established US office. Situated at the heart of UCLA’s campus, Magnify offers high-quality, affordable facilities, expert services, and a vibrant innovation ecosystem to help transformative technology startups thrive.

With CosmoSort now operational at Magnify, Meteor Biotech is ready to welcome researchers and drug developers from across the United States. Scientists working in oncology, neurology, immunology, and biomarker discovery can now access the company’s proprietary Spatially-Resolved Laser-Activated Cell Sorting (SLACS) technology for advanced single-cell analysis.

Unlike conventional spatial omics platforms that primarily chart expression profiles across tissue samples, SLACS enables researchers to isolate and extract specific cells from tissue sections with unprecedented speed and accuracy, allowing for far deeper and more detailed analyses.

“Meteor Biotech is excited to establish our new office at the Magnify Incubator,” said Dr Amos Lee, co-founder and CEO of Meteor Biotech. “This milestone represents a significant step in our growth and reinforces our commitment to innovation and collaboration within the CNSI ecosystem. By installing CosmoSort, we are providing researchers with unparalleled single-cell analysis capabilities, and we anticipate this will accelerate breakthrough discoveries. The alignment between our mission and Magnify’s vision for supporting transformative startups makes this partnership an ideal fit.”

Academic scientists and drug developers will be able to take part in hands-on trials, demonstrations, and pilot studies using CosmoSort. Meteor Biotech will also provide on-site trials and customer training to ensure optimal use of the technology.

“Magnify is thrilled to welcome Meteor Biotech to our incubator,” said Nikki Lin, Director of the Magnify Incubator at CNSI. “Their decision to establish a US office here and make advanced scientific equipment accessible reflects the collaborative and innovative environment we aim to cultivate. By providing researchers with cutting-edge tools, Meteor Biotech is not only strengthening our ecosystem but also contributing to the broader scientific community. Together, we look forward to driving impactful advances in biotechnology and fostering a culture of innovation and excellence.”

More information online